Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

161.

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.

Lancet.
Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, Polasek R, Contant CF, McCabe CH, Braunwald E.
| Sep 5, 2009
162.

HPV vaccine for all.

Lancet.
Michels KB, zur Hausen H.
| Jul 25, 2009
163.

Multiple myeloma.

Lancet.
Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC.
| Jul 25, 2009
164.

Bladder cancer.

Lancet.
Kaufman DS, Shipley WU, Feldman AS.
| Jul 18, 2009
165.

Diabetes: finding "a clean well-lighted place".

Lancet.
Jacobson AM.
| May 23, 2009
166.

Gestational diabetes mellitus: an opportunity of a lifetime.

Lancet.
Bentley-Lewis R.
| May 23, 2009
167.

Painless jaundice with serial multi-organ dysfunction.

Lancet.
Khosroshahi A, Stone JR, Pratt DS, Deshpande V, Stone JH.
| Apr 25, 2009
168.

Can the polypill save the world from heart disease?

Lancet.
Cannon CP.
| Apr 18, 2009
169.

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Lancet.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ.
| Apr 4, 2009
170.

Caregiving: the odyssey of becoming more human.

Lancet.
Kleinman A.
| Jan 24, 2009
171.

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

Lancet.
Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
| Feb 7, 2009
172.

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.

Lancet.
Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH.
| Dec 6, 2008
173.

Violence and the role of illness narratives.

Lancet.
Westerhaus M, Panjabi R, Mukherjee J.
| Aug 30, 2008
174.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

Lancet.
Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS.
| Oct 18, 2008
175.

Promise of improving metabolic and lifestyle risk in practice.

Lancet.
Mozaffarian D.
| Jun 14, 2008
177.

Liver cirrhosis.

Lancet.
Schuppan D, Afdhal NH.
| Mar 8, 2008
178.

Activated vitamin D sterols in kidney disease.

Lancet.
Thadhani R.
| Feb 16, 2008
179.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Lancet.
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.
| Feb 2, 2008
180.

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.

Lancet.
Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L, Woulfe K, Pravda E, Cassiola F, Desai J, George S, Morgan JA, Harris DM, Ismail NS, Chen JH, Schoen FJ, Van den Abbeele AD, Demetri GD, Force T, Chen MH.
| Dec 15, 2007